Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Association of genetically proxied cancer-targeted drugs with cardiovascular diseases through Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 12:20
  • Read more about Association of genetically proxied cancer-targeted drugs with cardiovascular diseases through Mendelian randomization analysis

Effects of immune cells in mediating the relationship between inflammatory bowel disease and pyoderma gangrenosum: a two-sample, two-step mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 12:10
  • Read more about Effects of immune cells in mediating the relationship between inflammatory bowel disease and pyoderma gangrenosum: a two-sample, two-step mendelian randomization study

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 11:56
  • Read more about Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 11:37
  • Read more about Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study

Appraising the Effects of Gut Microbiota on Insomnia Risk Through Genetic Causal Analysis

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:55
  • Read more about Appraising the Effects of Gut Microbiota on Insomnia Risk Through Genetic Causal Analysis

Genetic evidence of the causal relationships between psychiatric disorders and cardiovascular diseases

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:52
  • Read more about Genetic evidence of the causal relationships between psychiatric disorders and cardiovascular diseases

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:47
  • Read more about Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study

SNP rs6543176 is associated with extreme human longevity but increased risk for cancer

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:41
  • Read more about SNP rs6543176 is associated with extreme human longevity but increased risk for cancer

Causal relationship between 14 micronutrients and chronic periodontitis: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:36
  • Read more about Causal relationship between 14 micronutrients and chronic periodontitis: a Mendelian randomization study

The impact of common and rare genetic variants on bradyarrhythmia development

Submitted by Frida Mäkelä on Tue, 01/14/2025 - 16:31
  • Read more about The impact of common and rare genetic variants on bradyarrhythmia development

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 167
  • Page 168
  • Page 169
  • Page 170
  • Current page 171
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement